subclinical hypothyrodism
TRANSCRIPT
![Page 1: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/1.jpg)
Subclinical hypothyroidism
Dr.YASSIN ALSALEH
![Page 2: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/2.jpg)
![Page 3: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/3.jpg)
![Page 4: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/4.jpg)
CASE SCENARIO• 4 year old child case of chronic
constipation ,obesity found to have abnormal TFT:• TSH :8 high FT4:17 normal • what is the next step???
![Page 5: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/5.jpg)
Synonyms • Compensated hypothyroidism.• latent hypothyroidism. • preclinical hypothyroidism. • euthyroid
hyperthyrotropinemia.
![Page 6: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/6.jpg)
Introduction• Definition:• SCH is biochemically defined
as (TSH) is above the upper-limit of the statistically defined reference range • while the serum free
thyroxine (FT4) is within its reference range.
TSH↑
FT4 N
![Page 7: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/7.jpg)
Laboratory definition• TSH is secreted in a pulsatile manner
and shows diurnal variation.• The levels may vary based on the
time of sampling as well as its relation to food.• TSH is false high In about 0.5 to 5%
of patient samples.
![Page 8: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/8.jpg)
Laboratory definition
mildly increased (4.5–10 mIU/l) severely increased (>10 mIU/l)
TSH
Pediatric > one month of age
![Page 9: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/9.jpg)
• The prevalence of SCH in the pediatric population is 2%
EPIDEMIOLOGY
![Page 10: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/10.jpg)
![Page 11: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/11.jpg)
Manifestations• Asymptomatic.
• A goiter is the most common manifestation.
![Page 12: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/12.jpg)
• weight gain.• increased cholesterol levels.• impaired growth velocity.• anemia.• sleepiness, weakness.• impaired psychomotor and cognitive
development.
Manifestations
![Page 13: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/13.jpg)
etiologycauses
anatomicallythyroidal
others(association)
pathophysiologicalidiopathic
autoimmune
![Page 14: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/14.jpg)
Thyroidal Causes• Autoimmune thyroiditis
(HASHIMOTOS) . (most common) 50-80% of cases.• Developmental anomalies
(hypoplasia, hemiagensis). • TSH Resistance syndrome (RTSH).
![Page 15: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/15.jpg)
other causes • newborns classified false positive at
congenital hypothyroidism screening .(up to 70%)• SGA . Up to 50% .• Down’s syndrome. up to 32%• William’ syndrome. Up to 31.5%.
![Page 16: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/16.jpg)
others• diabetes mellitus (11%).• cystic fibrosis.• celiac disease. • chronic renal failure.
• obesity up to 25%.
![Page 17: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/17.jpg)
![Page 18: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/18.jpg)
Natural History and Progression
TSH
Normalized 30-40%
>70% if TSH
<10
Overt hypothyroi
dism 1-10% Up to
20% if Autoimm
une
SCH
![Page 19: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/19.jpg)
ProgressionNon-autoimmune ‘idiopathic’ SCH
• either discovered on newborn screening or later during childhood.• normalizes in 36–88% of patients
![Page 20: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/20.jpg)
Progression• Risk factor for progression to overt
hypothyroidism• Goiter.• TSH levels.• Presence of thryoglobulin antibody. • progressive increase in anti-thyroid
peroxidase (TPO) antibodies .• female sex.• family history of thyroid disorder
![Page 21: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/21.jpg)
Therapy
• There is no consensus on therapy of SCH in children.
![Page 22: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/22.jpg)
Therapy
NO YES
![Page 23: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/23.jpg)
• Studies analyzing height, growth velocity, and puberty did not confirm a negative influence of SH.
• few studies showed beneficial effect on idiopathic short stature and SCH.
Effects of Therapy on Growth velocity
![Page 24: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/24.jpg)
• Studies showed improve metabolic control in type 1 diabetics.• improvement in growth velocity.
• Improvement was better in patients with higher TSH at entry.
Effects of Therapy on diabetic patients
![Page 25: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/25.jpg)
Therapy in Autoimmune Thyroid Disease
• Prophylactic L-T4 therapy of patients with euthyroid AITD reduces serological markers of autoimmune thyroiditis.• L-T4 therapy might be useful for
stopping progression of the disease.
![Page 26: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/26.jpg)
Therapy (goiter)
• L-thyroxine therapy reduce thyroid volume in those patients with goiter.
![Page 27: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/27.jpg)
Therapy (obese child)
• hyperthyrotropinemia in obesity is a consequence rather than a cause.
• therefore L-T4 therapy is unnecessary in obese children.
• Patients should be encouraged to implement appropriate diet and exercise programs
![Page 28: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/28.jpg)
![Page 29: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/29.jpg)
Therapy (migrane)
• children aged between 5 and 15 yrs diagnosed with SH suffered more frequently from the migraines which were also lasting longer.
![Page 30: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/30.jpg)
Effects of SCH on Neuropsychological Development
• Neuropsychological Development was not impaired in patient with SH as compared to euthyroid children.
![Page 31: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/31.jpg)
Effects of SCH on Cardiovascular system
• children and adolescents with SCH were found to have significant impairment of diastolic and longitudinal systolic cardiac function on echocardiography
![Page 32: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/32.jpg)
Effects of SCH on lipid metabolisim
• A significantly higher concentration of serum total and low-density lipoprotein (LDL) cholesterol was found in children with SCH as compared to euthyroid children
![Page 33: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/33.jpg)
![Page 34: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/34.jpg)
Management • TSH between 4.5 and 10 mIU/l should be
followed-up.
• TSH > 10 mIU/l with normal FT4 levels may be treated.
• Especially in presence of :1- goiter .2- positive antibodies .3- signs and symptoms.
![Page 35: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/35.jpg)
Management
• Start with small dose.• Monitor TFT every 6-8 weeks.• Consider imaging if TSH is
persistently high.
![Page 36: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/36.jpg)
conclusion• SH in children seems to be a remitting
process with a low risk of evolution toward overt hypothyroidism.
• The initial presence of goiter and elevated TG-Abs and a progressive increase in TPO-Abs and TSH values predict a progression toward overt hypothyroidism.
![Page 37: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/37.jpg)
• Replacement therapy is not justified in children with SH but with TSH 4.5–10 mIU/l, no goiter, and negative antithyroid antibodies
conclusion
![Page 38: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/38.jpg)
References 1- Seshadri KG. Subclinical hypothyroidism in
children.Indian J Endocrine Metababolisim 2012;16:S156-8.
2-FRANCESCA CALACIURA . Subclinical Hypothyroidism in Early Childhood:A Frequent Outcome of Transient Neonatal Hyperthyrotropinemia .The Journal of Clinical Endocrinology & Metabolism 87(7):3209–3214
![Page 39: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/39.jpg)
References3- M SHRIRAAM AND M SRIDHAR .Subclinical
Hypothyroidism in Children . INDIAN PEDIATRICS .VOLUME 51-NOVEMBER 15, 2015
4- Yardena Tenenbaum-Rakover. Approach to Subclinical Hypothyroidism in Children. http://dx.doi.org/10.5772/5513.2013
5- John Lazarus. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. Eur Thyroid J 2014;3:76–94
![Page 40: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/40.jpg)
References
6-Aneta Gawlik. Subclinical Hypothyroidism in Children and Adolescents:Is It Clinically Relevant? International Journal of Endocrinology. 2015.
7-Wasniewska M, Elevated TSH levels normalize or remain unchanged in the majority of children with subclinical hypothyroidism. Eur J Endocrinol 2009;160:417-21.
![Page 41: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/41.jpg)
References8- Alice Monzani,Natural history of subclinical
hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. European Journal of Endocrinology (2013) 168 R1–R11
9- Emel Torun1, Subclinical hypothyroidism in obese children .Dicle Medical Journal.2013
![Page 42: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/42.jpg)
![Page 43: subclinical hypothyrodism](https://reader035.vdocuments.net/reader035/viewer/2022062900/58ee34911a28abb42c8b45af/html5/thumbnails/43.jpg)